Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

B Harvey Cash


  • Director at Ciena Corp (CIEN), 2018-04-05
  • Director at Argo Group International Holdings Ltd. (AGII), 2017-12-06
  • Director at First Acceptance Corp (FAC), 2017-05-11
  • Director at Silicon Laboratories Inc (SLAB), 2015-02-20
  • Large Shareholder at Applied Genetic Technologies Corp (AGTC), 2014-04-01
  • Large Shareholder at Macrogenics Inc (MGNX), 2013-10-19
  • Large Shareholder at Tesaro Inc. (TSRO), 2012-07-06
  • Large Shareholder at Transcept Pharmaceuticals Inc (TSPT), 2011-09-23
  • Other at Epocrates Inc (EPOC), 2011-02-07
  • Other at Trius Therapeutics Inc (TSRX), 2010-08-10
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CIEN $24.28 700 Director 97,778 2017-01-05 Filing
AGII $63.95 4,163 Director 9,958 2016-11-29 Filing
CIEN $19.66 800 Director 89,033 2015-12-14 Filing
CIEN $18.25 1,000 Director 78,559 2014-12-16 Filing
AGII $57.52 2,213 Director 3,347 2014-12-03 Filing